Despite the approval of second-generation antiobesity medications, metabolic and bariatric surgery (MBS) use among US adolescents increased from 2021 to 2023.

From 2020 to 2023, there was an increase in the rates of fentanyl-involved nonfatal overdose emergency department visits.